Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- NTHI
- Price
- 8.75
- Stock movement up
- +0.69 (8.56%)
- Company name
- NeOnc Technologies Holdings, Inc. Common Stock
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 166.48M
- Ent value
- 180.87M
- Price/Sales
- 2775.20
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
NTHI does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2775.20 |
| Price to Book | - |
| EV to Sales | 3014.98 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 19.03M |
| EPS (TTM) | -2.84 |
| FCF per share (TTM) | -0.92 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 59.99K |
| Gross profit (TTM) | 59.99K |
| Operating income (TTM) | -52.33M |
| Net income (TTM) | -54.55M |
| EPS (TTM) | -2.84 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 100.00% |
| Operating margin (TTM) | -87236.58% |
| Profit margin (TTM) | -90933.59% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.51M |
| Net receivables | 0.00 |
| Total current assets | 2.96M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 379.51K |
| Total assets | 4.08M |
| Accounts payable | 499.90K |
| Short/Current long term debt | 378.74K |
| Total current liabilities | 15.59M |
| Total liabilities | 15.90M |
| Shareholder's equity | -11.81M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -17.73M |
| Capital expenditures (TTM) | 14.00 |
| Free cash flow (TTM) | -17.73M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -1336.08% |
| Return on Invested Capital | 464.49% |
| Cash Return on Invested Capital | 150.94% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 8.08 |
| Daily high | 8.83 |
| Daily low | 8.08 |
| Daily Volume | 41K |
| All-time high | 12.09 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | -2.84 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| NTHI | S&P500 | |
| Current price drop from All-time high | -27.63% | -0.89% |
| Highest price drop | -51.53% | -19.00% |
| Date of highest drop | 21 Nov 2025 | 8 Apr 2025 |
| Avg drop from high | -22.15% | -2.49% |
| Avg time to new high | 21 days | 6 days |
| Max time to new high | 74 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
166.48M
Marketcap category
Small-cap
Description
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trials for the treatment of glioblastoma; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration to patients with primary and secondary brain tumors. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. NeOnc Technologies Holdings, Inc. was incorporated in 2005 and is headquartered in Calabasas, California.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partner